Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.
about
Molecular targets for flavivirus drug discoveryPyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cellsEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentPharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerFiloviruses: One of These Things is (not) Like the OtherMouse models for filovirus infectionsProgress towards the treatment of Ebola haemorrhagic fever."Filoviruses": a real pandemic threat?Antiviral activity of a small-molecule inhibitor of filovirus infectionPharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMSDeterminants of sensitivity to DZNep induced apoptosis in multiple myeloma cells.Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.EZH2: biology, disease, and structure-based drug discoveryPharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cellsCombined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cellsHistone methylases as novel drug targets: developing inhibitors of EZH2.Antivirals and antiviral strategies.Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in Rodents.Imino sugar glucosidase inhibitors as broadly active anti-filovirus agentsDevelopments in antivirals against influenza, smallpox and hemorrhagic fever viruses.Correlates of immunity to filovirus infection.Curious discoveries in antiviral drug development: the role of serendipity.New substituted benzimidazole derivatives: a patent review (2013 - 2014).Development of Small-Molecule Antivirals for Ebola.Viral Epitranscriptomics.3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death.The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).Emerging role of SETDB1 as a therapeutic target.Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication.Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.Targeting methionine cycle as a potential therapeutic strategy for immune disorders.Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent.Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.S-Adenosyl-L-homocysteine hydrolase is sequestered into actin rods in Dictyostelium discoideum spores.John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity.Addition of m6A to SV40 late mRNAs enhances viral structural gene expression and replication.Flexibility-Not just for yoga anymore!Evaluation of the impact of S-adenosylmethionine-dependent methyltransferase inhibitor, 3-deazaneplanocin A, on tissue injury and cognitive function in mice.Strategies in the Design of Antiviral DrugsA guided tour through the antiviral drug field
P2860
Q21999123-8AE6A4B8-C250-4B9B-927A-ED334FB10CF7Q24562099-F9CD3DAB-2EAA-4413-BAA2-F0EF1A37A24FQ24597625-8B5463C2-014B-4AD0-BF66-F20C01149828Q24632276-28E90FC8-5EB1-4A06-8DF7-D45BA0FCF13CQ26783063-A961ECFD-D462-4DC6-A954-9BEC25FD69B4Q27011569-1E338071-4EAD-4AF4-BF40-A729F643F04BQ30230272-8A6FA3F7-2983-405B-83FE-EC60317762C1Q30384090-135466BE-E10C-4C09-BB7F-3F009632A842Q33538454-E07B92F1-90A0-4278-B429-DAA7C642ED2DQ33592489-1AF9BC2A-7900-455B-80A9-36A940008ADDQ33948015-C6D4E645-2513-4CC3-ADF7-32F763BFEE5FQ34040052-6DDD00F2-DF10-40E2-92AC-809877B51609Q34393753-0E16DA84-B9A3-4215-8E54-CD87AC715683Q34619655-56DA1CCE-97E0-4BFA-8712-57412F35EF50Q34994576-CD5085E3-5185-47BB-ABD7-8512C57CE7F4Q35510392-9276D82C-C509-44CA-AA3E-CF6EA75C658BQ35889586-5D529310-17CD-4643-8274-5607AED606E0Q36433538-53F5332E-3296-4909-A54A-05450A86EA56Q37584342-0BEA2206-EEEB-44B3-B932-DD4E6900E5B4Q37828538-796C41AC-6428-44A3-B443-80F9AFE4F7E2Q37945233-E9E5AFC1-0896-4BB2-9CC9-5E1F73E6824CQ38366289-1E618CB9-E5BA-46AD-8BD5-73DCEA524B33Q38426805-1075DD07-B3D9-4624-8604-3013D10CFE1DQ38546746-39FE7C48-BBD4-46F7-91F3-781E517D9E60Q38934931-30D8A65C-78A2-4F4A-AE84-728ED28CA4AFQ38947403-E994DB58-CE41-48E3-ACE9-7B8022214FAEQ39064876-866C1E2A-6218-4809-8928-5E40FBFEE1A6Q39079803-957E6F56-CBA7-42F0-B5F1-EA1A9C629811Q40041108-235204C6-4A22-4A0E-B81D-8B2DB06FB2E2Q40054455-1FA960A5-2062-4D04-B00E-244014917E7AQ40075590-AE154CE5-B61F-4D9B-AAA5-BFC1734DBCE1Q40591012-45A802E3-4E52-4746-84D0-196009C60775Q41687420-BA5E551D-2A0B-40F9-AEC8-AF2DF62187DFQ43812268-51C54FCF-C3C4-4126-BC2C-19C5240B66B4Q44091038-6FB4B4AD-BBDF-4E53-A888-22DB9B6936D8Q49979102-1741B3E3-4913-4C7D-9188-EBB13EB00691Q52691809-0E8CA040-FAC0-43C7-BB49-E66BFEC4B34DQ54988946-9C944288-ABD7-4017-9F75-A75C56263549Q56786281-4C92F9C5-5277-4151-83CE-9FD279AEE2ABQ56786373-E489F5AA-19E2-4984-BAC1-D2E504039931
P2860
Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Treatment of lethal Ebola viru ...... ocysteine hydrolase inhibitor.
@en
type
label
Treatment of lethal Ebola viru ...... ocysteine hydrolase inhibitor.
@en
prefLabel
Treatment of lethal Ebola viru ...... ocysteine hydrolase inhibitor.
@en
P2093
P1433
P1476
Treatment of lethal Ebola viru ...... ocysteine hydrolase inhibitor.
@en
P2093
P304
P356
10.1016/S0166-3542(00)00066-8
P577
2000-02-01T00:00:00Z